Hip Impingement Syndrome Clinical Trial
Official title:
Weight Bearing as Tolerated (WBAT) Following Hip Arthroscopic Labral Repair and Femoroplasty.
Verified date | April 2024 |
Source | University of Pittsburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is being proposed to examine weight bearing precautions following hip arthroscopic labral repair, femoroplasty, and capsular closure. Standard post operative protocols limit weight bearing for 2-6 weeks depending on individual surgeons. Cadaveric studies demonstrate that minimal force during weight bearing is distributed through labrum. Therefore, progressing weight bearing earlier in these patients post operatively may help progress faster and improve outcomes. Data collected will include demographic information, radiological data, operative procedures and PRO data.
Status | Enrolling by invitation |
Enrollment | 80 |
Est. completion date | July 28, 2025 |
Est. primary completion date | January 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age>= 12 years - Diagnoses: femoroacetabular impingement and hip labral tears. - Surgical procedures performed: Hip arthroscopy with femoroplasty and labral repair. - Surgery completed at UPMC Children's or UPMC St. Margaret's Hospital - unilateral and bilateral hip patients Exclusion Criteria: - MSK tumor-related FAI or dysplasia - generalized hypermobility - revision surgeries |
Country | Name | City | State |
---|---|---|---|
United States | UPMC Hip Preservation Program | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | International Hip Outcome Tool 12 (iHot-12) | Scoring ranges from 0-100
each question is rated from 0-100 and final score is the mean of all questions answered by subject higher scoring indicating higher quality of life due to hip function |
up to 6 months post-operative | |
Primary | Hip and Groin Outcome Score (HAGOS) | This outcome includes 6 subscales, these are scored independently, and no aggregate scoring is calculated as each section assesses different dimensions separately.
Subscales (raw scores for each subscale converted to a 0-100 scale with higher score indicating higher level of function): Pain Symptoms Activities of Daily Life Function in Sport and recreation Participation in Physical Activities hip and groin-related quality of life |
up to 6 months post-operative | |
Primary | Hip Outcome Score (HOS) ADL | Outcome assessing function with activities of daily living. Higher score is given for higher level of function and lower score indicating reduced function.
0-68 aggregate scoring converted to 0-100 scale. |
up to 6 months post-operative | |
Primary | Hip Outcome Score (HOS) Sport | Outcome assessing function/difficulty completing dynamic activities associated with sports participation. Higher score is given for higher level of function and lower score indicating reduced function.
0-36 aggregate scoring converted to 0-100 scale. |
up to 6 months post-operative | |
Primary | Tampa Scale for Kinesiophobia-11 | Outcome measure assessing fear of pain with movement. Scores range from 11 to 44. Higher scores indicate greater fear of movement | up to 6 months post-operative | |
Secondary | Isometric strength measures hip add, abd, ER, and extension | Strength measures will be taken isometrically at post-operative follow ups. | 6-week, 3 months, and 6-month post-operative | |
Secondary | Diagnostic ultrasound assessment of bilateral anterior hip capsule thickness | Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.
Ultrasound will measure the following: 1.Assess the bilateral hip anterior capsule in all patients, assessing for internal consistency or changes in capsular thickness from side to side. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm. |
3 months post-operative | |
Secondary | Diagnostic ultrasound assessment of incision widening | Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.
1. Evaluation of capsular incision widening, cyst, attenuation and thinning from established norms. Normal hip capsular thickness has been reported as 7-8 mm, dysplastic hips range 3.2 +/- 0.5 mm, and femoroacetabular impingement subjects 4.7 +/- 0.6 mm |
3 months post-operative | |
Secondary | Diagnostic ultrasound for focal echogenic adhesions | Physician while blinded will perform ultrasound evaluation of the hip capsule to ensure healing.
1. Evaluate for focal echogenic adhesions or dyskinetic motion between capsule and overlying iliopsoas complex with activation of hip flexion. |
3 months post-operative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05893823 -
Retrospective Study on Radiological Factors Predictive of Psoas Impingement
|
||
Completed |
NCT05310240 -
Analysis of the Relevance of Radiologic Parameters on the Outcome After Hip Arthroscopy
|
||
Withdrawn |
NCT05710146 -
Tranexamic Acid (TXA) in Hip Arthroscopy
|
Phase 3 | |
Terminated |
NCT04212650 -
Losartan to Improve Hip Microfracture
|
Phase 1/Phase 2 |